共 11 条
[1]
Use of B-type natriuretic peptide in evaluation of early percutaneous coronary intervention in patients with acute coronary syndrome[J]. 蒋晨阳,李楠,王建安.Chinese Medical Journal. 2004(08)
[2]
Plasma levels of N-terminal pro-brain natriuretic peptide in patients with coronary artery disease and relation to clinical presentation, angiographic severity, and left ventricular ejection fraction[J] . The American Journal of Cardiology . 2005 (5)
[3]
BNP as A Biomarker in Heart Disease[J] . Olli Vuolteenaho,Minna Ala‐Kopsala,Heikki Ruskoaho.Advances in Clinical Chemistry . 2005
[5]
N-Terminal Pro-Brain Natriuretic Peptide and Other Risk Markers for the Separate Prediction of Mortality and Subsequent Myocardial Infarction in Patients With Unstable Coronary Artery Disease: A Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV Substudy[J] . Stefan K James,Bertil Lindahl,Agneta Siegbahn,Mats Stridsberg,Per Venge,Paul Armstrong,Elliot S Barnathan,Robert Califf,Eric J Topol,Maarten L Simoons,Lars Wallentin.Circulation . 2003 (3)
[7]
N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease[J] . Tomas Jernberg,Bertil Lindahl,Agneta Siegbahn,Bertil Andren,Gunnar Frostfeldt,Bo Lagerqvist,Mats Stridsberg,Per Venge,Lars Wallentin.Journal of the American College of Cardiology . 2003 (11)
[8]
Evaluation of B-type natriuretic peptide for risk assessment in unstable Angina/Non–ST-elevation myocardial infarction[J] . David A. Morrow,James A. de Lemos,Marc S. Sabatine,Sabina A. Murphy,Laura A. Demopoulos,Peter M. DiBattiste,Carolyn H. McCabe,C.Michael Gibson,Christopher P. Cannon,Eugene Braunwald.Journal of the American College of Cardiology . 2003 (8)